then FDA approval of psychedelics may be a matter of “when” not “if.” MAPS Executive Director Rick Doblin has been working to legalize MDMA for PTSD since the 1980's as ... [+] well as ...

Dr. Brian Barnett, a psychiatrist who heads psychedelic research at the Cleveland Clinic in Ohio, also said he thinks MDMA will be eventually approved for PTSD, despite the FDA’s decision.

Two small studies submitted to the FDA suggested combining MDMA with talk therapy led to significant easing of PTSD symptoms.

The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...

See Also: FDA Rejects MDMA For PTSD Treatment, Calls For More Research On Psychedelic Therapy For advocates of psychedelic medicine, this rejection is a major setback. April Pride, CEO and founder ...

A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the ...

More than 70 percent of the MDMA group no longer qualified for a PTSD diagnosis, compared to 48 percent of the control group. The FDA's advisers worried that the negative effects of MDMA-assisted ...

The U.S. Food and Drug Administration (FDA) has issued a complete response letter for MDMA-assisted psychotherapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD) in which it calls for ...

The Food and Drug Administration’s (FDA) recent rejection of midomafetamine (MDMA), along with mental health therapy, for the treatment of post-traumatic stress disorder (PTSD) came as no surprise.

Recommended Reading In tone-setting verdict, FDA rejects MDMA as a therapy aid for PTSD The CEO of Lykos Therapeutics will step down after the company’s efforts to win a milestone approval for ...